Cognition Therapeutics Inc (CGTX) — Financial Flexibility Index
Cognition Therapeutics Inc (CGTX) has a Financial Flexibility Index of -0.82x as of September 2025. Free cash flow of $-5.65 Million (operating CF $-5.65 Million minus capex $0.00) represents -1% of total liabilities ($6.87 Million). Check how strategically is Cognition Therapeutics Inc's equity deployed to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Cognition Therapeutics Inc Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Cognition Therapeutics Inc across 6 annual periods. See Cognition Therapeutics Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Cognition Therapeutics Inc (2019–2024)
Year-by-year free cash flow to debt coverage for Cognition Therapeutics Inc. For the full company profile including market capitalisation, see market cap of Cognition Therapeutics Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.48x | $-28.47 Million | $-28.47 Million | $11.48 Million | ▼ -67.0% |
| 2023 | -1.48x | $-15.87 Million | $-16.02 Million | $10.69 Million | ▲ +17.7% |
| 2022 | -1.80x | $-18.36 Million | $-18.53 Million | $10.18 Million | ▼ -293.7% |
| 2021 | -0.46x | $-3.60 Million | $-3.63 Million | $7.86 Million | ▼ -908.2% |
| 2020 | -0.05x | $-3.42 Million | $-3.43 Million | $75.30 Million | ▼ -1.4% |
| 2019 | -0.04x | $-2.95 Million | $-3.10 Million | $65.88 Million | — |